A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis
Clinical trial NCT04650854 · COMPLETED
Trial details
- NCT number
- NCT04650854
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-03
- Primary completion
- 2024-01-25
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.